This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
What's in Store for Prudential (PRU) This Earnings Season?
by Zacks Equity Research
Prudential's (PRU) Q3 results are likely to reflect improved spread income and emerging markets earnings, favorable underwriting, stronger related revenues, higher reinvestment and short-term rates.
What's in Store for Assurant (AIZ) This Earnings Season?
by Zacks Equity Research
Assurant's (AIZ) third-quarter performance is likely to have benefited from higher lender-placed policies in force in Homeowners, income from higher yields and modest growth in extended service contracts.
Will Arch Capital's (ACGL) Beat Streak Continue in Q3 Earnings?
by Zacks Equity Research
Arch Capital's (ACGL) third-quarter 2023 earnings are likely to reflect growth in most lines of business due to new business opportunities and rate increases, offset by higher expenses.
Enact Holdings, Inc. (ACT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
Enact Holdings, Inc. (ACT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Best Momentum Stocks to Buy for October 23rd
by Zacks Equity Research
KGC, VRT and ACT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 23, 2023.
What Awaits Arthur J. Gallagher (AJG) This Earnings Season?
by Zacks Equity Research
Arthur J. Gallagher's (AJG) third-quarter results are likely to reflect strong retention, new business generation, increasing renewal premiums and higher interest income, offset by higher expenses.
Everest Group (EG) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Everest Group's (EG) third-quarter results are likely to benefit from new business and strong renewal retention, the higher volume of ceding commissions, improved assets under management and rate increases.
Is a Beat in Store for CME Group (CME) This Earnings Season?
by Zacks Equity Research
CME Group's (CME) Q3 earnings are likely to have been aided by improved clearing, transaction fees and other revenues, and market data and information services. However, higher expenses might have been an offset.
Will Enact Holdings, Inc. (ACT) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Enact Holdings, Inc. (ACT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Are Finance Stocks Lagging Enact Holdings (ACT) This Year?
by Zacks Equity Research
Here is how Enact Holdings, Inc. (ACT) and Equinix (EQIX) have performed compared to their sector so far this year.
Are Finance Stocks Lagging Midwest Holding (MDWT) This Year?
by Zacks Equity Research
Here is how Midwest Holding Inc. (MDWT) and Enact Holdings, Inc. (ACT) have performed compared to their sector so far this year.
Radian (RDN) Up 35% YTD: Should You Buy It for Better Return?
by Zacks Equity Research
Radian (RDN) is poised to gain from improving mortgage insurance portfolio, declining claims, the well-performing homegenius segment, a solid capital position and effective capital deployment.
Are Finance Stocks Lagging Enact Holdings (ACT) This Year?
by Zacks Equity Research
Here is how Enact Holdings, Inc. (ACT) and Omega Healthcare Investors (OHI) have performed compared to their sector so far this year.
MGIC (MTG) Down 0.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
MGIC (MTG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Are Finance Stocks Lagging Enact Holdings (ACT) This Year?
by Zacks Equity Research
Here is how Enact Holdings, Inc. (ACT) and Omega Healthcare Investors (OHI) have performed compared to their sector so far this year.
Why Enact Holdings, Inc. (ACT) Might be Well Poised for a Surge
by Zacks Equity Research
Enact Holdings, Inc. (ACT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Enact Holdings, Inc. (ACT) Q2 Earnings Beat Estimates
by Zacks Equity Research
Enact Holdings, Inc. (ACT) delivered earnings and revenue surprises of 34.15% and 2.81%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
EverQuote (EVER) Exits Health Business to Improve Efficiency
by Zacks Equity Research
EverQuote (EVER) streamlines its operations by exiting from the health insurance business.
MetLife (MET) Expands Partnership With DentalInsurance.com
by Zacks Equity Research
MetLife (MET) collaborates with DentalInsurance.com to provide impeccable service to customers purchasing dental health insurance.
Here's Why Hold Strategy is Apt for Coinbase Global (COIN)
by Zacks Equity Research
Coinbase Global (COIN) should benefit from an enhanced product suite and reduced operating expenses in the future.
Here's Why Investors Should Hold Cigna (CI) Stock for Now
by Zacks Equity Research
Cigna's (CI) strong Evernorth and Cigna Healthcare segments, growing medical membership and a positive 2023 outlook poise it well for growth.
MetLife (MET) and Lyra Unite to Improve Employee Mental Health
by Zacks Equity Research
MetLife (MET) partners with Lyra to provide employees with mental health solutions and improve their well-being in difficult situations.
Here's Why You Should Hold American Equity (AEL) Stock for Now
by Zacks Equity Research
AEL 2.0 strategy, strong annuity product sales and an aging U.S. population poise American Equity (AEL) well for growth.
Is Enact Holdings (ACT) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Enact Holdings, Inc. (ACT) and Capital Southwest (CSWC) have performed compared to their sector so far this year.
MetLife (MET) Launches Pet Health and Wellness App With Microsoft
by Zacks Equity Research
MetLife (MET) launches an enhanced pet insurance app with Microsoft to help pet parents.